DIOVAN HCT- valsartan and hydrochlorothiazide tablet, film coated Estados Unidos - inglés - NLM (National Library of Medicine)

diovan hct- valsartan and hydrochlorothiazide tablet, film coated

dispensing solutions, inc. - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - diovan hct (valsartan and hydrochlorothiazide, usp) is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including hydrochlorothiazide and the arb class to which valsartan principally belongs. there are no controlled trials demonstrating risk reduction with diovan hct. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national comm

DIOVAN HCT- valsartan and hydrochlorothiazide tablet, film coated Estados Unidos - inglés - NLM (National Library of Medicine)

diovan hct- valsartan and hydrochlorothiazide tablet, film coated

pd-rx pharmaceuticals, inc. - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - diovan hct (valsartan and hydrochlorothiazide, usp) is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including hydrochlorothiazide and the angiotensin ii receptor blocker (arb) class to which valsartan principally belongs. there are no controlled trials demonstrating risk reduction with diovan hct. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than 1 drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education

DIOVAN- valsartan tablet Estados Unidos - inglés - NLM (National Library of Medicine)

diovan- valsartan tablet

aphena pharma solutions - tennessee, llc - valsartan (unii: 80m03yxj7i) (valsartan - unii:80m03yxj7i) - valsartan 80 mg - diovan® (valsartan) is indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including the class to which valsartan principally belongs. there are no controlled trials in hypertensive patients demonstrating risk reduction with diovan. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluati

CO-DIOVAN 160/12.5 mg/mg Film Coated Tablet Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan 160/12.5 mg/mg film coated tablet

b & s healthcare - valsartan, hydrochlorothiazide - film coated tablet - 160/12.5 mg/mg - angiotensin ii antagonists and diuretics

CO-DIOVAN 160/25 mg/mg Film Coated Tablet Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan 160/25 mg/mg film coated tablet

b & s healthcare - valsartan hydrochlorothiazide - film coated tablet - 160/25 mg/mg

CO-DIOVAN Film Coated Tablet 160/12.5 Milligram Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan film coated tablet 160/12.5 milligram

profind wholesale ltd. - valsartan hydrochlorothiazide - film coated tablet - 160/12.5 milligram

CO-DIOVAN Film Coated Tablet 160/25 Milligram Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan film coated tablet 160/25 milligram

profind wholesale ltd. - valsartan hydrochlorothiazide - film coated tablet - 160/25 milligram

CO-DIOVAN Film Coated Tablet 80/12.5 Milligram Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan film coated tablet 80/12.5 milligram

profind wholesale ltd. - valsartan hydrochlorothiazide - film coated tablet - 80/12.5 milligram

CO-DIOVAN Film Coated Tablet 80/12.5 Milligram Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan film coated tablet 80/12.5 milligram

clear pharmacy - valsartan hydrochlorothiazide - film coated tablet - 80/12.5 milligram

CO-DIOVAN Film Coated Tablet 160/12.5 Milligram Irlanda - inglés - HPRA (Health Products Regulatory Authority)

co-diovan film coated tablet 160/12.5 milligram

clear pharmacy - valsartan hydrochlorothiazide - film coated tablet - 160/12.5 milligram